Skye BioscienceSKYE 13F holders, Q2 2024 (June 30) 62 holders +59
59 new positions
0 sold out
2 famous investors
$8.01 avg. 13F price*
At the end of Q2 2024 , 62 institutions reported holding Skye Bioscience Inc. (SKYE) in their 13F filings, up 59 from Q1 2024. 59 opened new positions and 0 sold out. The largest holders were 5AM Venture Management, LLC ($81.5M), Versant Venture Management, LLC ($16.1M) and Altium Capital Management LLC ($10.8M). 2 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
Company Skye Bioscience Inc.
CUSIP 83086J200
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024 Institutions Total Value New Positions 59 $180.1M Exits 0 $0
All 13F filers, Q1 2024 → Q2 2024: 22,478,167 shares bought, net +22,478,167 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 62 holders Portfolio Manager % of Holder's Portfolio Change vs Q1 2024 Shares Value ▼ 5AM Venture Management, LLC 18.24% New 10,179,505 $81.5M Versant Venture Management, LLC 20.81% Add +0.0% 2,007,704 $16.1M Altium Capital Management LLC 4.48% New 1,350,093 $10.8M Logos Global Management LP 1.20% New 1,301,518 $10.4M Sphera Funds Management LTD. 1.70% New 1,298,312 $10.4M BlackRock Inc. 0.00% New 1,118,767 $9.0M Janus Henderson Group PLC 0.00% New 905,650 $7.3M Vanguard Group Inc. 0.00% New 833,620 $6.7M CVI Holdings, LLC 5.12% New 679,739 $5.4M Driehaus Capital Management LLC 0.05% New 650,758 $5.2M Point72 Asset Management 0.01% New 560,000 $4.5M Perceptive Advisors LLC 0.10% New 500,000 $4.0M Baker Bros. Advisors LP 0.05% New 500,000 $4.0M Schonfeld Strategic Advisors LLC 0.03% New 431,355 $3.5M Velan Capital Investment Management LP 1.94% New 422,142 $3.4M Geode Capital Management, LLC 0.00% New 370,179 $3.0M State Street Corp. 0.00% New 331,004 $2.7M Alyeska Investment Group, L.P. 0.01% New 300,000 $2.4M Citadel Advisors 0.00% New 265,587 $2.1M Bank of New York Mellon Corp 0.00% New 58,778 $471K Charles Schwab Investment Management Inc. 0.00% New 51,656 $414K Northern Trust Corp. 0.00% New 42,469 $340K Barclays PLC 0.00% New 42,338 $339K NEOS Investment Management LLC 0.01% New 31,647 $253K Point72 Asia (Singapore) Pte. Ltd. 0.05% New 27,768 $222K BNP Paribas Financial Markets 0.00% New 27,713 $222K AdvisorShares Investments LLC 0.04% New 26,000 $210K Nuveen Asset Management, LLC 0.00% New 23,389 $187K Morgan Stanley 0.00% New 21,472 $172K Rhumbline Advisers 0.00% New 19,754 $158K Alpine Global Management, LLC 0.03% New 16,807 $135K JPMorgan Chase & Co. 0.00% New 14,971 $120K New York State Common Retirement Fund 0.00% New 13,800 $111K Bank of America Corp. 0.00% New 11,570 $93K Corebridge Financial, Inc. 0.00% — 9,264 $74K Deutsche Bank AG 0.00% New 8,781 $70K Wells Fargo & Company 0.00% New 7,272 $58K Point72 (DIFC) Ltd 0.00% New 6,000 $48K UBS Group AG 0.00% New 5,250 $42K MetLife Investment Management, LLC 0.00% New 4,796 $38K Citigroup Inc. 0.00% New 3,848 $31K Cubist Systematic Strategies, LLC 0.00% New 3,762 $30K STRS Ohio 0.00% New 3,200 $26K Royal Bank of Canada 0.00% New 1,709 $14K Ameritas Investment Partners, Inc. 0.00% New 1,687 $14K Financial Gravity Asset Management, Inc. 0.00% No change 1,600 $13K Legal & General Group Plc 0.00% New 1,486 $12K California State Teachers Retirement System 0.00% New 1,248 $10K Amalgamated Bank 0.00% New 596 $5K Federation des caisses Desjardins du Quebec 0.00% New 51 $409 Dunhill Financial, LLC 0.00% New 50 $401 NFSG Corp 0.00% New 18 $144 Asset Dedication, LLC 0.00% New 16 $129 CoreCap Advisors, LLC 0.00% New 8 $64 Beacon Capital Management, LLC 0.00% New 8 $64 Harbour Investments, Inc. 0.00% New 7 $56 Plante Moran Financial Advisors, LLC 0.00% New 3 $24 IFP Advisors, Inc 0.00% New 3 $24 Principal Securities, Inc. 0.00% New 2 $16 TD Waterhouse Canada Inc. 0.00% New 2 $16 PFS Partners, LLC 0.00% New 1 $9 Tucker Asset Management LLC 0.00% No change 1 $8
"% of holder's portfolio" is SKYE's weight in each manager's 13F, not the share of Skye Bioscience Inc. the manager owns.